130 Episodio

  1. Do You Really Lose Muscle on Semaglutide or Tirzepatide?

    Pubblicato: 22/08/2025

  2. Predatory Lab Testing: What They’re Not Telling You

    Pubblicato: 16/08/2025

  3. CVS Pulled the Plug on Zepbound?!

    Pubblicato: 08/08/2025

  4. More Than Weight Loss? GLP-1s and Cardiovascular Risk

    Pubblicato: 03/08/2025

  5. Semaglutide vs. Tirzepatide: Are We Closing the Gap?

    Pubblicato: 24/07/2025

  6. Clinical vs Anthropometric Obesity

    Pubblicato: 02/07/2025

  7. GLP-1 meds and macular degeneration

    Pubblicato: 23/06/2025

  8. Menopause, MHT, and GLP-1 medicines

    Pubblicato: 12/06/2025

  9. The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass

    Pubblicato: 06/06/2025

  10. Current State of Nutrition Research and MAHA

    Pubblicato: 29/05/2025

  11. Joy Prescriptions

    Pubblicato: 13/05/2025

  12. Zepbound versus Wegovy

    Pubblicato: 12/05/2025

  13. Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH).

    Pubblicato: 02/05/2025

  14. Top 5 Women's Fitness Myths

    Pubblicato: 25/04/2025

  15. GLP-1 and metabolism and depression

    Pubblicato: 11/04/2025

  16. Do GLP-1 meds cause more fat cells?

    Pubblicato: 19/03/2025

  17. Future of medicine - Direct Care

    Pubblicato: 11/03/2025

  18. Tirzepatide and Muscle Loss with Dr. Grant Tinsley

    Pubblicato: 28/02/2025

  19. The Super Bowl Hims and Hers Ad

    Pubblicato: 17/02/2025

  20. NAD and NMN with Dr. Charles Brenner

    Pubblicato: 12/02/2025

1 / 7

Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.

Visit the podcast's native language site